Published in EMBO J on October 21, 2015
Deciphering Transcriptome and Complex Alternative Splicing Transcripts in Mammary Gland Tissues from Cows Naturally Infected with Staphylococcus aureus Mastitis. PLoS One (2016) 1.39
Structure and activation of C1, the complex initiating the classical pathway of the complement cascade. Proc Natl Acad Sci U S A (2017) 0.89
Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined. Proc Natl Acad Sci U S A (2016) 0.82
Lectin Complement Pathway Proteins in Healthy Individuals. Clin Exp Immunol (2016) 0.80
Solution Structures of Complement C2 and Its C4 Complexes Propose Pathway-specific Mechanisms for Control and Activation of the Complement Proconvertases. J Biol Chem (2016) 0.79
Genetic Investigation of Complement Pathway Genes in Type 2 Diabetic Retinopathy: An Inflammatory Perspective. Mediators Inflamm (2016) 0.76
Complement regulatory proteins CFHR1 and CFHR3 and patient response to anti-CD20 monoclonal antibody therapy. Clin Cancer Res (2016) 0.75
The dual role of complement in cancer and its implication in anti-tumor therapy. Ann Transl Med (2016) 0.75
Moonlighting of Helicobacter pylori catalase protects against complement-mediated killing by utilising the host molecule vitronectin. Sci Rep (2016) 0.75
Plasma levels of MASP-1, MASP-3 and MAp44 in patients with type 2 diabetes: influence of glycaemic control, body composition and polymorphisms in the MASP1 gene. Clin Exp Immunol (2017) 0.75
Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3. J Biol Chem (2016) 0.75
Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis. Cell (2017) 0.75
Functional and structural insight into properdin control of complement alternative pathway amplification. EMBO J (2017) 0.75
Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targets. J Leukoc Biol (2016) 0.75
Plasmin as a complement C5 convertase. EBioMedicine (2016) 0.75
Evolution and Function of Thioester-Containing Proteins and the Complement System in the Innate Immune Response. Front Immunol (2017) 0.75
Untangling Fc and complement receptors to kill tumors. Nat Immunol (2017) 0.75
FCN-A/2, acting as a new regulator of macrophage polarization, mediates the inflammatory response in experimental mouse colitis. Immunology (2017) 0.75
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum (1992) 14.73
Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement. J Exp Med (1967) 6.72
Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte. J Exp Med (1980) 6.49
The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med (1990) 6.19
Systemic lupus erythematosus disease activity index 2000. J Rheumatol (2002) 6.11
Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron (2012) 5.84
Atypical hemolytic-uremic syndrome. N Engl J Med (2009) 5.66
Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med (1972) 5.61
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med (1984) 5.47
Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med (2006) 5.26
Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol (2004) 5.14
Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J Exp Med (1975) 4.69
CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration. Nat Genet (2006) 4.51
Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol (2007) 4.46
Role of C5a in inflammatory responses. Annu Rev Immunol (2005) 4.38
Structures of complement component C3 provide insights into the function and evolution of immunity. Nature (2005) 4.01
Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement. J Exp Med (1973) 3.83
Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest (1970) 3.55
The sterile inflammatory response. Annu Rev Immunol (2010) 3.45
Functional roles for C5a receptors in sepsis. Nat Med (2008) 3.33
Structure of C3b reveals conformational changes that underlie complement activity. Nature (2006) 3.22
Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense. Science (2007) 3.13
Immunoglobulin G: functional sites. Mol Immunol (1985) 3.12
Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood (2009) 2.97
Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest (2003) 2.96
The role of the anaphylatoxins in health and disease. Mol Immunol (2009) 2.95
CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell (2006) 2.89
Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J Exp Med (1981) 2.88
Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature (2006) 2.69
Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway. J Exp Med (1976) 2.66
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature (2011) 2.64
Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol (2000) 2.59
Structure of complement fragment C3b-factor H and implications for host protection by complement regulators. Nat Immunol (2009) 2.54
The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci (2012) 2.53
Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nat Immunol (2009) 2.49
Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. J Am Soc Nephrol (2004) 2.46
Genetic and environmental factors influencing the human factor H plasma levels. Immunogenetics (2004) 2.43
The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med (2003) 2.38
Structural basis for engagement by complement factor H of C3b on a self surface. Nat Struct Mol Biol (2011) 2.32
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat Genet (2005) 2.20
Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity (2013) 2.19
The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Sci (1997) 2.12
Molecular intercommunication between the complement and coagulation systems. J Immunol (2010) 2.12
Identification of complement regulatory domains in human factor H. J Immunol (1995) 2.02
Structural basis for complement factor H linked age-related macular degeneration. J Exp Med (2007) 2.02
Factor H family proteins and human diseases. Trends Immunol (2008) 2.02
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor. Nat Immunol (2009) 1.98
Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol (1998) 1.96
An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum Mol Genet (2010) 1.95
Human factor H-related protein 5 has cofactor activity, inhibits C3 convertase activity, binds heparin and C-reactive protein, and associates with lipoprotein. J Immunol (2005) 1.92
Genetic variants in C5 and poor response to eculizumab. N Engl J Med (2014) 1.91
Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens. J Immunol (1985) 1.91
A new map of glycosaminoglycan and C3b binding sites on factor H. J Immunol (2008) 1.89
MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity (2001) 1.84
Isolation and characterization of a mannan-binding protein from human serum. J Biochem (1983) 1.83
The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum. J Immunol (1978) 1.81
C1 inhibitor and hereditary angioneurotic edema. Annu Rev Immunol (1988) 1.80
Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab Invest (1991) 1.79
His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J Biol Chem (2006) 1.79
Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol (2006) 1.78
Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet (2013) 1.77
Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J Immunol (2007) 1.74
The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem (2009) 1.73
A novel role of complement: mice deficient in the fifth component of complement (C5) exhibit impaired liver regeneration. J Immunol (2001) 1.73
Complement control protein factor H: the good, the bad, and the inadequate. Mol Immunol (2010) 1.68
Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. J Immunol (1996) 1.68
Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta (2003) 1.66
The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin Exp Immunol (2004) 1.65
Interaction between the coagulation and complement system. Adv Exp Med Biol (2008) 1.65
Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun (2005) 1.64
Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc Natl Acad Sci U S A (2013) 1.63
Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J Immunol (2006) 1.63
Complement inhibitor C4b-binding protein-friend or foe in the innate immune system? Mol Immunol (2004) 1.61
The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell (2004) 1.60
Structures of C3b in complex with factors B and D give insight into complement convertase formation. Science (2010) 1.59
Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein. Crit Rev Immunol (2000) 1.59
C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition. J Immunol (2008) 1.59
Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome. Blood (2015) 1.58
Factor H-related protein-5: a novel component of human glomerular immune deposits. Am J Kidney Dis (2002) 1.56
Structural basis of mannan-binding lectin recognition by its associated serine protease MASP-1: implications for complement activation. Structure (2011) 1.55
Investigations on the pattern recognition molecule M-ficolin: quantitative aspects of bacterial binding and leukocyte association. J Leukoc Biol (2011) 1.55
Complement is activated by IgG hexamers assembled at the cell surface. Science (2014) 1.52
MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of Carnevale, Malpuech, OSA, and Michels syndromes. Am J Hum Genet (2010) 1.51
Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D. J Exp Med (2009) 1.51
The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. Proc Natl Acad Sci U S A (2008) 1.51
Paths reunited: Initiation of the classical and lectin pathways of complement activation. Immunobiology (2009) 1.50
The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin Exp Immunol (2006) 1.50
Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H. Eur J Immunol (1996) 1.46
The role of complement in B cell activation and tolerance. Adv Immunol (2000) 1.43
Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome. Nat Genet (2011) 1.43
Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin. FEBS Lett (1999) 1.43
Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family. J Biol Chem (1998) 1.40
Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol Immunol (2006) 1.40
A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease. J Immunol (2003) 1.40
Paroxysmal nocturnal hemoglobinuria. Blood (2014) 1.39
Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat Genet (2013) 1.39
3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase. Proc Natl Acad Sci U S A (2009) 1.38
Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. J Biol Chem (2007) 1.36
The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol Immunol (2004) 1.35
Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol (2000) 1.34